Rajangam Kanya (CIK 1816676) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-11). Recent activity: Sell SNTI (10,757 shares), Sell SNTI (1,384 shares), Buy SNTI (33,000 shares), Buy SNTI (78,363 shares), Sell SNTI (1,297 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Sell | 10,757 | $0 |
| 2026-02-03 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Sell | 1,384 | $0 |
| 2025-03-11 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Buy | 33,000 | $74,250 |
| 2025-03-10 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Buy | 78,363 | $0 |
| 2025-02-06 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Sell | 1,297 | $5,279 |
| 2025-02-06 | Senti Biosciences, Inc. (SNTI) | Pres. & Chief Med. & Dev. Off. | Sell | 182 | $795 |
Source: SEC Form 4 filings · as of 2026-03-11